In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous

Liver Metastases of Small Intestine Neuroendocrine Tumors

(2015) Chanjuan Shi et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Does Somatostatin or Gastric Inhibitory Peptide Receptor Expression Correlate with Tumor Grade and Stage in Gut Neuroendocrine Tumors?

(2015) Meike K�rner et al.   NEUROENDOCRINOLOGY

Therapeutic strategies for neuroendocrine liver metastases

(2014) Andrea Frilling et al.   CANCER

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

(2014) Martyn E. Caplin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Free Somatostatin Receptor Fraction Predicts the Antiproliferative Effect of Octreotide in a Neuroendocrine Tumor Model: Implications for Dose Optimization

(2013) P. Heidari et al.   CANCER RESEARCH

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

(2013) John J. Zaknun et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Peptide receptor radionuclide therapy of neuroendocrine tumors with 90Y-DOTATOC: Is treatment response predictable by pre-therapeutic uptake of 68Ga-DOTATOC?

(2013) M.Ö. Öksüz et al.   Diagnostic and Interventional Imaging

Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms

(2011) Günter Klöppel   ENDOCRINE-RELATED CANCER

Targeted Radiotherapy with Radiolabeled Somatostatin Analogs

(2011) Guillaume Nicolas et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment

(2011) H. R. Maecke et al.   JOURNAL OF NUCLEAR MEDICINE

Radiopeptide Imaging and Therapy in Europe

(2011) V. Ambrosini et al.   JOURNAL OF NUCLEAR MEDICINE

Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

(2010) Dik J. Kwekkeboom et al.   SEMINARS IN NUCLEAR MEDICINE

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY